Incyte (INCY) Q4 Results: Revenue Surpasses Estimate; EPS Misses Outlook

Incyte Corp. (INCY) released Q4 earnings of $299.3 million, or $1.46 per share GAAP, and $1.80 per share adjusted. Revenue reached $1.51 billion, exceeding forecasts, while net income missed the average analyst estimate of $1.94 per share. Year-over-year, the specialty drugmaker posted profit of $1.29 billion, or $6.41 per share, on revenue of $5.14 billion.